# Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

> **NCT01227954** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 113 (actual)

## Conditions studied

- Cognitive/Functional Effects
- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT01227954
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-05
- **Final completion:** 2016-12
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2017-09-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227954, "Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01227954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*